EPS Bio Technology Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 112.39 million compared to TWD 100.4 million a year ago. Revenue was TWD 112.39 million compared to TWD 100.4 million a year ago. Net income was TWD 4.18 million compared to TWD 4.95 million a year ago. Basic earnings per share from continuing operations was TWD 0.18 compared to TWD 0.21 a year ago. Diluted earnings per share from continuing operations was TWD 0.18 compared to TWD 0.21 a year ago.
For the six months, sales was TWD 203.26 million compared to TWD 213.06 million a year ago. Revenue was TWD 203.26 million compared to TWD 213.06 million a year ago. Net income was TWD 6.6 million compared to TWD 7.46 million a year ago. Basic earnings per share from continuing operations was TWD 0.28 compared to TWD 0.31 a year ago. Diluted earnings per share from continuing operations was TWD 0.28 compared to TWD 0.31 a year ago.